Top Market Shifts Transforming the Implantable Cardiac Rhythm Management Device Market Landscape: Key Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Implantable Cardiac Rhythm Management Device Market Through 2025?
The market size of implantable cardiac rhythm management devices has consistently expanded over the recent years. An increase from $17.06 billion in 2024 to $17.87 billion in 2025 is expected, implying a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this growth during the historic period include the older population, increased occurrence of cardiac arrhythmias, efforts towards awareness and education, developments in healthcare infrastructure, and escalating healthcare spending.

What's the Projected Size of the Global Implantable Cardiac Rhythm Management Device Market by 2029?
In the coming years, the market for implantable cardiac rhythm management devices is projected to experience robust growth. It is forecasted to expand to "$23.27 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%. Numerous factors are contributing to this projected growth during the forecast period. These include the transition to leadless devices, the practice of remote patient monitoring, emphasis on managing heart failure, increased usage in developing markets, and partnering for research and development purposes. Key trends for the forecast period encompass the development of bioresorbable technologies, incorporation of artificial intelligence (AI), technological advancements, the use of telemedicine and remote monitoring, improvements in leadless pacemakers, wireless charging, and power management.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Top Growth Drivers in the Implantable Cardiac Rhythm Management Device Industry: What's Accelerating the Market?
The rising frequency of heart diseases is predicted to propel the expansion of the implantable cardiac rhythm management devices market. Cardiac disorders include any disease that impacts the heart or circulation. Implantable cardiac rhythm management devices assist patients suffering from heart failure and diminished left ventricular function by enhancing systolic function through the resynchronization of heart contractions and restoration of a normal heartbeat during severe rapid ventricular arrhythmias. Consequently, the escalating occurrence of heart diseases will amplify the need for implantable cardiac rhythm management devices. For example, in September 2024, the British Heart Foundation, a cardiovascular research charity based in the UK, revealed that nearly 7.6 million people in the UK suffer from heart and circulatory diseases, including about 4 million males and 3.6 million females. Responsible for approximately 27% of all UK deaths, these diseases result in over 170,000 deaths per year, equating to about 480 deaths daily or one death every three minutes. Therefore, the mounting prevalence of heart diseases is fueling implantable cardiac rhythm management devices market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10117&type=smp

What Trends Will Shape the Implantable Cardiac Rhythm Management Device Market Through 2029 and Beyond?
Technological advancement is driving growth in the implantable cardiac rhythm management devices market. In April 2022, US-based Rhythm Management Group PLLC unveiled RhythmSynergy, a platform that combines machine learning with clinical expertise to analyze data from implantable and wearable devices. It streamlines patient monitoring and reporting, offering timely insights for better cardiac care.

What Are the Main Segments in the Implantable Cardiac Rhythm Management Device Market?
The implantable cardiac rhythm management device market covered in this report is segmented -

1) By Device: Cardiac Resynchronization Therapy, Defibrillators, Pacemakers
2) By Application: Bradycardia, Tachycardia, Other Applications
3) By End-Use: Hospitals, Specialty Cardiac Centers, Other End-Uses

Subsegments:
1) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker), CRT-D (Defibrillator)
2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs), Subcutaneous Implantable Defibrillators (S-ICDs)
3) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10117&type=smp

Which Top Companies are Driving Growth in the Implantable Cardiac Rhythm Management Device Market?
Major companies operating in the implantable cardiac rhythm management device market include Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik Ltd., MicroPort Scientific Corporation, Abiomed Inc, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology Co. Ltd., LivaNova PLC, Shenzhen Mindray Biomedical Electronics Co. Ltd, Progetti Srl, Edwards Lifesciences Corporation, Cardiac Science Corporation, Bardy Diagnostics Inc., Beijing Demax Medical Technology Co. Ltd, iRhythm Technologies Inc., Impulse Dynamics plc., VytronUS Inc.

Which Regions Will Dominate the Implantable Cardiac Rhythm Management Device Market Through 2029?
North America was the largest region in the implantable cardiac rhythm management device market in 2024. The regions covered in the implantable cardiac rhythm management device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10117

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.